Breaking News Instant updates and real-time market news.

CVS

CVS Health

$75.65

2.45 (3.35%)

, SRCL

Stericycle

$67.63

-0.93 (-1.36%)

09:55
01/04/18
01/04
09:55
01/04/18
09:55

Early notable gainers among liquid option names on January 4th

Notable gainers among liquid option names this morning include CVS Health (CVS) $76.11 +2.93, Stericycle (SRCL) $69.54 +1.94, TEGNA (TGNA) $14.59 +0.39, F5 Networks (FFIV) $137.74 +3.66, and General Motors (GM) $43.92 +1.10.

CVS

CVS Health

$75.65

2.45 (3.35%)

SRCL

Stericycle

$67.63

-0.93 (-1.36%)

TGNA

Tegna

$14.62

0.42 (2.96%)

FFIV

F5 Networks

$134.04

1.46 (1.10%)

GM

General Motors

$43.63

0.8051 (1.88%)

  • 04

    Jan

  • 04

    Jan

  • 08

    Jan

  • 09

    Jan

  • 16

    Jan

  • 24

    Jan

  • 01

    Mar

CVS CVS Health
$75.65

2.45 (3.35%)

01/04/18
RAJA
01/04/18
UPGRADE
RAJA
Strong Buy
CVS Health upgraded to Strong Buy from Outperform at Raymond James
01/03/18
PIPR
01/03/18
UPGRADE
Target $207
PIPR
Overweight
Aetna upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Sarah James upgraded Aetna (AET) to Overweight and raised her price target for the shares to $207 from $187. The analyst sees a potential "win-win" scenario surrounding the outcome of the CVS Health (CVS) buyout. If the deal goes through James sees 15% share upside. If the deal does not go through, Aetna is set up for "strong operational performance" with stock appreciation potential of 15% by year end, the analyst contends.
01/02/18
NEED
01/02/18
NO CHANGE
Target $88
NEED
Buy
CVS Health will have multiple 2018 catalysts, says Needham
Needham analyst Kevin Caliendo raised his price target on CVS Health (CVS) to $88 from $85 while keeping his Buy rating. Caliendo says he has been frustrated on the lack of movement in the stock following the Aetna (AET) merger announcement, attributing "investor apathy" to confusion over the management's guidance and lack of clarity around the tax reform impact. The analyst estimates that the company's corporate tax rate will move to about 26% from 39% and also models about $1 in net positive EPS accretion from the Aetna deal in 2019. Caliendo lists the company's S-4 filing in early January and the road show promoting the merger as key catalysts in the near term.
01/04/18
RAJA
01/04/18
UPGRADE
Target $90
RAJA
Strong Buy
CVS Health upgraded to Strong Buy on Aetna deal, valuation at Raymond James
Raymond James analyst John Ransom upgraded CVS (CVS) to Strong Buy from Outperform and maintained a $90 price target. Ransom has increased conviction in the Aetna (AET) deal and believes the Street's implied probability of 40% likelihood of receiving regulatory approval is too low. Further, the analyst said CVS is poised for growth in 2018 given easier comps, an increase in Medicare Part D lives, and tax reform, and views valuation as attractive.
SRCL Stericycle
$67.63

-0.93 (-1.36%)

12/28/17
STFL
12/28/17
NO CHANGE
Target $85
STFL
Buy
Stericycle likely to guide conservatively, focus message on FCF, says Stifel
After meeting with Stericycle CEO Charlie Alutto, Stifel analyst Michael Hoffman said he believes Alutto understands that the company needs to revisit its message and may need to "shrink to grow." Hoffman predicts the company will give conservative FY18 guidance in February and may possibly write-down some businesses as a precursor to a sale, though he doesn't see the company as far enough along to identify any "assets-held-for-sale." Hoffman, who also expects the company to refocus its message around its high quality free cash flow, reiterates his Buy rating and $85 target price on Stericycle shares.
12/13/17
JEFF
12/13/17
NO CHANGE
Target $83
JEFF
Buy
Stericycle valuation should improve with concessions, says Jefferies
Jefferies analyst Sean Dodge says competitive pricing data and three separate analyses indicate Stericycle will have to concede $120M-$150M in price to retain the bulk of its domestic small quantity regulated medical waste client base. This compares to management's $130M estimate and appears to be well below the amount the stock is currently pricing in, Dodge tells investors in a research note. He notes that he's seen some estimates as high as $365M. The analyst sees Stericycle's valuation improving as concessions track toward his estimate. Further, tax reform could add meaningfully to Stericycle's earnings next year, Dodge writes. He keeps a Buy rating on the shares with an $83 price target.
11/10/17
BMOC
11/10/17
NO CHANGE
Target $62
BMOC
Market Perform
Stericycle price target lowered to $62 from $74 at BMO Capital
BMO Capital analyst Jeffrey Silber lowered his price target on Stericycle to $62 and kept his Market Perform rating after a Q3 earnings miss that was driven by lower-than-expected revenues and margins, higher EMEA costs, and hurricanes impact. Silber adds the outlook was also mixed, anticipating core business efficiencies to offset some price headwinds and result in roughly flat earnings next year. Given the "various moving parts", the analyst says he remains "cautious" while reducing his price target estimates.
11/09/17
RBCM
11/09/17
NO CHANGE
Target $67
RBCM
Underperform
Stericycle price target lowered to $67 from $74 at RBC Capital
RBC Capital analyst Gary Bisbee lowered his price target on Stericycle to $67 and kept his Underperform rating following Q3 earnings miss. Bisbee says the company's Manufacturing and Industrial segment continues to limit its overall growth, adding that Regulated Waste business was also disappointing. The analyst notes that while the announcement of widespread restructuring is likely a long-term positive, it will take time to deliver results.
TGNA Tegna
$14.62

0.42 (2.96%)

09/26/17
RBCM
09/26/17
INITIATION
RBCM
Sector Perform
Tegna initiated with a Sector Perform at RBC Capital
RBC Capital started coverage of Tegna with a $14 price target and a Sector Perform rating. Analyst Leo Kulp thinks that a "choppy ad market" could cause the company's 2017 results to miss expectations, but he thinks that the company's 2018 results could beat expectations, and he says that it is well-positioned to benefit from "intramarket deregulation." Kulp says he could become more "constructive on the stock into 2018."
09/26/17
09/26/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. DowDuPont (DWDP) initiated with a Hold at HSBC. 2. Lilis Energy (LLEX) initiated with a Buy at Williams Capital. 3. Alder Biopharmaceuticals (ALDR) initiated with an Outperform at Cowen. 4. Corium (CORI) initiated with a Buy at H.C. Wainwright. 5. Tegna (TGNA) initiated with a Sector Perform at RBC Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/04/18
WELS
01/04/18
UPGRADE
Target $19
WELS
Outperform
Tegna upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Marci Ryvicker upgraded Tegna to Outperform and raised her price target for the shares to $19 from $14. The analyst sees "a lot of potential upside" in 2018 given the company's exposure to NBC. She sees the channel benefitting from the Super Bowl and Olympics, as well as the mid-term elections.
10/18/17
GUGG
10/18/17
INITIATION
Target $17
GUGG
Buy
Tegna initiated with a Buy at Guggenheim
Guggenheim initiated Tegna with a Buy and $17 price target.
FFIV F5 Networks
$134.04

1.46 (1.10%)

10/26/17
SBSH
10/26/17
NO CHANGE
Target $150
SBSH
Buy
F5 Networks signaled bottom in fundamentals, says Citi
Citi analyst Jim Suva points out that on last night's conference call, F5 Networks said every quarter after December will see quarter-over-quarter sales growth. This is, in essence, management calling for a bottom in its fundamentals, Suva tells investors in a post-earnings research note. He believes investors will be skeptical of F5's guidance given the disappointing 2017 coupled with the stock down 18% year-to-date. Suva reiterates a Buy rating on the shares with a $150 price target.
01/04/18
BMOC
01/04/18
UPGRADE
Target $156
BMOC
Outperform
F5 Networks upgraded to Outperform at BMO Capital on turnaround in software
As reported earlier, BMO Capital analyst Tim Long upgraded F5 Networks to Outperform from Market Perform and raised his price target to $156 from $122. Long says the stock is "ripe for a turnaround" based on the "recurring nature" in software. The analyst notes the spending cycle has reached an inflection as customers settle on their cloud architecture, adding that U.S. tax reform and further stock buybacks may support F5 shares. Long adds that the current valuation of 15-times CY18 EPS undervalues the stock, whose five-year average is around 17-times.
10/06/17
NOMU
10/06/17
NO CHANGE
Target $275
NOMU
Buy
Nomura Instinet lays out potential takeover targets for Broadcom
With revenues this year on track to reach $17B, few opportunities in the semiconductor space exist that would move the needle for Broadcom Limited (AVGO), Nomura Instinet analyst Romit Shah tells investors in a research note. As a result, the analyst believes the company could be looking to acquire companies in peripheral spaces. Shah's analysis yields CA Technologies (CA), NetApp (NTAP), Juniper (JNPR), Garmin (GRMN), Trimble (TRMB), Akamai (AKAM), F5 Networks (FFIV), Ciena (CIEN) and EchoStar (SATS) as possible takeover targets. The analyst thinks Broadcom shares may continue to "languish" in the near term given uncertainty with the Brocade acquisition and iPhone supply constraints. Shah, however, remains optimistic in Broadcom's ability to generate $20-plus in earnings per share in the future. He keeps a Buy rating on the shares with a $275 price target.
01/04/18
BMOC
01/04/18
UPGRADE
BMOC
Outperform
F5 Networks upgraded to Outperform from Market Perform at BMO Capital
GM General Motors
$43.63

0.8051 (1.88%)

12/28/17
MSCO
12/28/17
NO CHANGE
MSCO
January to be busy for Autos and Shared Mobility names, says Morgan Stanley
Morgan Stanley analyst Adam Jonas previewed the January calendar for the Autos and Shared Mobility sector, noting that the Vegas CES takes place in the second week and the Detroit Auto Show occurs in the third week of next month. Judging from last year's shows and press releases in recent weeks, he expects "the vast majority" of prepared presentations will focus on autonomous driving, electric propulsion and new business models as companies seek to encourage recognition and valuation of "Auto 2.0 efforts" in the multiples of their stocks, he tells investors. Automakers covered by the firm include Fiat Chrysler (FCAU), Tesla (TSLA), General Motors (GM), Ferrari (RACE) and Ford (F). Auto suppliers covered include Magna (MGA), Goodyear Tire (GT), Adient (ADNT), Delphi Technologies (DLPH), Visteon (VC), BorgWarner (BWA), Aptiv (APTV) and Tenneco (TEN).
12/19/17
12/19/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. General Motors (GM) upgraded to Outperform from Sector Perform at RBC Capital with analyst Joseph Spak citing "increased confidence on downturn resiliency" in 2018, noting that while he anticipates a decline in fullsize pickup truck sales, he does not see "GMNA profitability to be down as much as previously forecast". 2. Walmart (WMT) upgraded to Buy from Neutral at Citi with analyst Kate McShane saying the stock has "more room to run" in 2018. 3. Ulta Beauty (ULTA) upgraded to Buy from Neutral at Buckingham with the firm saying they recommend adding to positions given "extremely" attractive valuation and better flow through profitability that will deliver 20%+ earnings growth over the next two years or more. 4. Cabot (CBT) upgraded to Buy from Hold at SunTrust with analyst James Sheehan saying the improving global supply/demand fundamentals, along with tighter emissions controls in China, warrant the rating change. 5. Altria Group (MO) upgraded to Buy from Hold at Berenberg with analyst Jonathan Leinster saying he assumes that the company's headline tax rate will decline from historical levels of 35-36% to 21-22% due to the Republicans' proposed U.S. corporate tax changes. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/19/17
RBCM
12/19/17
UPGRADE
Target $52
RBCM
Outperform
General Motors upgraded to Outperform at RBC Capital on downturn resiliency
As reported earlier, RBC analyst Joseph Spak upgraded Generat Motors to Outperform from Sector Perform and nudged his price target to $52 from $51. Spak cites "increased confidence on downturn resiliency" in 2018, noting that while he anticipates a decline in fullsize pickup truck sales, he does not see "GMNA profitability to be down as much as previously forecast". The analyst models FY18 EPS of $6.30, about 9% above consensus view.
12/19/17
RBCM
12/19/17
UPGRADE
RBCM
Outperform
General Motors upgraded to Outperform from Sector Perform at RBC Capital

TODAY'S FREE FLY STORIES

BOLD

Audentes Therapeutics

$33.74

0.7 (2.12%)

20:43
08/20/18
08/20
20:43
08/20/18
20:43
Initiation
Audentes Therapeutics initiated at Citi »

Audentes Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

VNOM

Viper Energy

$38.06

-0.29 (-0.76%)

20:42
08/20/18
08/20
20:42
08/20/18
20:42
Upgrade
Viper Energy rating change at Citi »

Viper Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCPH

scPharmaceuticals

$4.94

-0.43 (-8.01%)

20:25
08/20/18
08/20
20:25
08/20/18
20:25
Recommendations
scPharmaceuticals analyst commentary at BMO Capital »

scPharmaceuticals'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

MDT

Medtronic

$90.06

-0.54 (-0.60%)

, TJX

TJX

$101.68

1.33 (1.33%)

20:25
08/20/18
08/20
20:25
08/20/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

MDT

Medtronic

$90.06

-0.54 (-0.60%)

TJX

TJX

$101.68

1.33 (1.33%)

SJM

J.M. Smucker

$115.92

1.35 (1.18%)

KSS

Kohl's

$78.86

2.43 (3.18%)

COTY

Coty

$12.41

0.19 (1.55%)

TOL

Toll Brothers

$34.72

0.33 (0.96%)

PINC

Premier

$38.35

-0.03 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 23

    Aug

  • 05

    Sep

  • 12

    Sep

  • 14

    Sep

BHP

BHP Billiton

$48.30

0.38 (0.79%)

19:33
08/20/18
08/20
19:33
08/20/18
19:33
Hot Stocks
Breaking Hot Stocks news story on BHP Billiton »

BHP CEO says looking to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGE

Tallgrass Energy

$26.23

0.63 (2.46%)

19:23
08/20/18
08/20
19:23
08/20/18
19:23
Recommendations
Tallgrass Energy analyst commentary at MUFG »

Tallgrass Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRY

Tilray

$35.91

5.2 (16.93%)

19:18
08/20/18
08/20
19:18
08/20/18
19:18
Hot Stocks
Tilray Canada reaches pact with OCRC to supply cannabis brands, products »

Tilray Canada announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

LFL

LATAM Airlines

$0.00

(0.00%)

19:10
08/20/18
08/20
19:10
08/20/18
19:10
Earnings
LATAM Airlines reports Q2 operating income $6.5M vs. $48.2M last year »

Reports Q2 revenue $2.36B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNOV

MediciNova

$8.99

-0.11 (-1.21%)

19:08
08/20/18
08/20
19:08
08/20/18
19:08
Hot Stocks
MediciNova says NIH awards research griant to UCLA for MN-166 trial »

MediciNova announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTZ

Hertz

$21.05

0.155 (0.74%)

, FN

Fabrinet

$44.00

0.365 (0.84%)

18:45
08/20/18
08/20
18:45
08/20/18
18:45
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

HTZ

Hertz

$21.05

0.155 (0.74%)

FN

Fabrinet

$44.00

0.365 (0.84%)

WDAY

Workday

$143.17

0.52 (0.36%)

SITO

Sito Mobile

$1.99

0.05 (2.58%)

NDSN

Nordson

$134.67

-0.12 (-0.09%)

APPN

Appian

$36.23

(0.00%)

CREE

Cree

$46.42

0.99 (2.18%)

MELI

MercadoLibre

$319.70

-4.3 (-1.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 20

    Aug

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 04

    Sep

  • 04

    Sep

  • 06

    Sep

  • 07

    Sep

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

  • 21

    Aug

IBKR

Interactive Brokers

$61.99

0.76 (1.24%)

18:43
08/20/18
08/20
18:43
08/20/18
18:43
Hot Stocks
FINRA fines Interactive Brokers $5.5M for regulation SHO violations »

FINRA announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$106.87

-0.71 (-0.66%)

18:29
08/20/18
08/20
18:29
08/20/18
18:29
Hot Stocks
LinkedIn to let economics researchers mine its data »

Microsoft's LinkedIn…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 12

    Sep

GSB

GlobalSCAPE

$3.46

(0.00%)

18:27
08/20/18
08/20
18:27
08/20/18
18:27
Hot Stocks
GlobalSCAPE to launch $15M modified Dutch auction tender offer »

GlobalSCAPE announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Oct

BHP

BHP Billiton

$48.30

0.38 (0.79%)

18:24
08/20/18
08/20
18:24
08/20/18
18:24
Earnings
BHP reports FY18 underlying profit $9.6B, consensus $9.2B according to Bloomberg »

BHP reports copper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$225.37

2.76 (1.24%)

18:19
08/20/18
08/20
18:19
08/20/18
18:19
Earnings
Lennox cuts FY18 adjusted EPS view to $8.90-$9.30 from $9.95-$10.35 »

FY18 consensus $10.25.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDI

Gardner Denver

$28.29

0.36 (1.29%)

18:10
08/20/18
08/20
18:10
08/20/18
18:10
Initiation
Gardner Denver initiated at Morgan Stanley »

Gardner Denver initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMM

3M

$204.57

-0.24 (-0.12%)

18:09
08/20/18
08/20
18:09
08/20/18
18:09
Initiation
3M initiated at Morgan Stanley »

3M initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETN

Eaton

$81.33

0.35 (0.43%)

18:05
08/20/18
08/20
18:05
08/20/18
18:05
Initiation
Eaton initiated at Morgan Stanley »

Eaton initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLS

Flowserve

$51.51

0.16 (0.31%)

18:01
08/20/18
08/20
18:01
08/20/18
18:01
Initiation
Flowserve initiated at Morgan Stanley »

Flowserve initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITW

Illinois Tool Works

$138.37

-1.05 (-0.75%)

17:59
08/20/18
08/20
17:59
08/20/18
17:59
Initiation
Illinois Tool Works initiated at Morgan Stanley »

Illinois Tool Works…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFX

Colfax

$33.28

0.62 (1.90%)

17:56
08/20/18
08/20
17:56
08/20/18
17:56
Initiation
Colfax initiated at Morgan Stanley »

Colfax initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALLE

Allegion

$86.97

0.26 (0.30%)

17:54
08/20/18
08/20
17:54
08/20/18
17:54
Initiation
Allegion initiated at Morgan Stanley »

Allegion initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGNX

Cognex

$52.42

0.02 (0.04%)

17:53
08/20/18
08/20
17:53
08/20/18
17:53
Initiation
Cognex initiated at Morgan Stanley »

Cognex initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTX

United Technologies

$135.14

0.73 (0.54%)

17:47
08/20/18
08/20
17:47
08/20/18
17:47
Periodicals
United Technologies buys analytics firm Predikto, Dow Jones says »

United Technologies has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCI

Johnson Controls

$38.73

0.48 (1.25%)

17:47
08/20/18
08/20
17:47
08/20/18
17:47
Initiation
Johnson Controls initiated at Morgan Stanley »

Johnson Controls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.